Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses

Clin Lab Med. 2022 Mar;42(1):97-109. doi: 10.1016/j.cll.2021.10.002. Epub 2021 Nov 3.

Abstract

Humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during acute infection and convalescence has been widely studied since March 2020. In this review, the authors summarize literature on humoral responses to SARS-CoV-2 antigens with a focus on spike, nucleocapsid, and the receptor-binding domain as targets of antibody responses. They highlight serologic studies during acute SARS-CoV-2 infection and discuss the clinical relevance of antibody levels in COVID-19 progression. Antibody responses in pediatric COVID-19 patients are also reviewed. Finally, the authors discuss antibody responses during convalescence and their role in protection from SARS-CoV-2 reinfection.

Keywords: Antigen-antibody responses; Coronavirus antigens; Humoral immunity; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Antibodies, Viral
  • Antibody Formation
  • COVID-19*
  • Child
  • Humans
  • Immunity, Humoral
  • SARS-CoV-2*

Substances

  • Antibodies, Viral